FDA Clearance & Incident Tracker
Tracker
A dated, filterable log of new FDA AI/ML device clearances, recalls, and reported clinical-AI incidents, sourced from FDA's AI-enabled device list, MAUDE reports, and other cited primary sources such as ECRI hazard reports. This is the site's freshness engine: every entry is timestamped, tagged by specialty and clearance pathway, states its sourcing and known limitations (e.g., MAUDE under-reporting, self-reported and unconfirmed incident causation), and links to any existing appraisal covering that device or tool category. Excludes narrative evaluation of evidence quality, which belongs to Appraisals, and excludes editorializing on fault or causation for incident entries.
Sourced from FDA's AI-enabled device list, MAUDE reports, and ECRI-style hazard reporting. MAUDE is self-reported and known to under-report; reported-incident entries do not confirm causation. Full sourcing and limitations are disclosed on Methodology.
EntryHow Keytruda Patent Cliff Redirects Cancer Drug R&DNew
EntryWhat past Medicaid work-requirement failures teach us about AI risksNew
EntryAI Claims Processing Errors Fuel Health Insurance LitigationNew
EntryWhy AI Copyright Settlements Matter for Medical AI DevelopmentNew
EntryWhy Tempus AI bought Personalis for its oncology platformNew
EntryHow AI Amplifies and Mitigates Healthcare Data BreachesNew
EntryHow Public Charge Rule Affects Immigrant Healthcare AccessNew
EntryHow AI Determines Car Accident Injury CompensationNew
EntryHow AI Optimizes Medical Cost Projections in Truck Accident ClaimsNew
EntryHow AI Tackles the Uninsured Motorist Claims CrisisNew
EntryHow Defense AI Computing Contracts Power Healthcare AI InfrastructureNew
EntryWhy Public Figures Face Unique Risks from AI Health TrackingNew
EntryWhat Hospitals Should Do When DNA Tests Reveal a Baby SwitchNew
EntryNetflix Scaled AI in Film Production in Under 12 MonthsNew
EntryWhy Statute of Limitations Fails in Switched-at-Birth CasesNew
EntryHow AI Is Reshaping Birth Injury LiabilityNew
EntryHow Brain Cancer Nonprofits Use AI to Boost FundraisingNew
EntryAI malpractice liability shifts to three parties under state capsNew
EntryHow Kimi K3 Compares to Claude and ChatGPT for HealthcareNew
EntryBill Marler's Cyclospora Lawsuits Expose Food Safety GapsNew
EntryWhy the Kimi K3 selloff hit semiconductor stocks unevenlyNew
EntryHow Ozempic's generic and authorized copy reshape South Africa's access gapNew
EntryMoonshot AI's Yang Zhilin on AGI, Long-Context, and the Kimi K3New
EntryHow AI Chip Earnings Are Fueling Healthcare AI AdoptionNew
EntryAI chips for healthcare: market forecast 2026–2033New